ATE331508T1 - Verwendung von 1-aminoindanderivaten zur behandlung der manie in verbindung mit manisch- depressiver erkrankung - Google Patents

Verwendung von 1-aminoindanderivaten zur behandlung der manie in verbindung mit manisch- depressiver erkrankung

Info

Publication number
ATE331508T1
ATE331508T1 AT00976661T AT00976661T ATE331508T1 AT E331508 T1 ATE331508 T1 AT E331508T1 AT 00976661 T AT00976661 T AT 00976661T AT 00976661 T AT00976661 T AT 00976661T AT E331508 T1 ATE331508 T1 AT E331508T1
Authority
AT
Austria
Prior art keywords
alkyl
hydrogen
unsubstituted
substituted
aralkyl
Prior art date
Application number
AT00976661T
Other languages
German (de)
English (en)
Inventor
Gabriela Barak
Ruth Levy
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Application granted granted Critical
Publication of ATE331508T1 publication Critical patent/ATE331508T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00976661T 1999-10-27 2000-10-27 Verwendung von 1-aminoindanderivaten zur behandlung der manie in verbindung mit manisch- depressiver erkrankung ATE331508T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16181799P 1999-10-27 1999-10-27

Publications (1)

Publication Number Publication Date
ATE331508T1 true ATE331508T1 (de) 2006-07-15

Family

ID=22582876

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00976661T ATE331508T1 (de) 1999-10-27 2000-10-27 Verwendung von 1-aminoindanderivaten zur behandlung der manie in verbindung mit manisch- depressiver erkrankung

Country Status (9)

Country Link
US (1) US6492426B1 (https=)
EP (1) EP1242066B1 (https=)
JP (1) JP2003512426A (https=)
AT (1) ATE331508T1 (https=)
AU (1) AU775885B2 (https=)
CA (1) CA2387394C (https=)
DE (1) DE60029131T2 (https=)
IL (2) IL149308A0 (https=)
WO (1) WO2001030339A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1200315A1 (en) 2011-10-10 2015-08-07 Teva Pharmaceutical Industries Ltd. R(+)-n-formyl-propargyl-aminoindan
US9181026B2 (en) 2013-10-03 2015-11-10 Custom Chemical Solutions, LLC Containment berm with internal “L” braces
WO2024196698A2 (en) * 2023-03-17 2024-09-26 Curadh Mtr Compounds and constructs useful for targeting fibroblast activation protein

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB852735A (en) 1956-04-13 1960-11-02 Schering Ag Manufacture of 1-aminoindanes
US3637740A (en) * 1969-04-21 1972-01-25 Pfizer Aminobenzocycloalkane compounds
BE786748A (fr) 1971-07-26 1973-01-26 Basf Ag 1-aminomethyl-indanes-n-substitues
US4096173A (en) * 1977-03-28 1978-06-20 Eli Lilly And Company Chlorinated 1-aminoindane N-methyl transferase inhibitors
JPS5824433A (ja) * 1981-08-06 1983-02-14 Takehiro Mokuzai Kogyo Kk 繊維材成型品の表面化粧方法
DE3407842A1 (de) 1983-03-04 1984-09-06 Otsuka Pharmaceutical Co. Ltd., Tokyo Indanderivate und deren salze, verfahren zu deren herstellung und arzneimittel und antioxidationsmittel, welche diese enthalten
US5242919A (en) 1984-08-31 1993-09-07 Otsuka Pharmaceutical Co., Ltd. 2,3-dihydro-1H-indene derivatives
JPS6169747A (ja) 1984-08-31 1986-04-10 Otsuka Pharmaceut Co Ltd 2,3―ジヒドロ―1h―インデン誘導体及びその製造法
DE3583780D1 (de) 1984-08-31 1991-09-19 Otsuka Pharma Co Ltd 2,3-dihydro-1h-inden-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
US4882339A (en) 1987-07-10 1989-11-21 Ciba-Geigy Corporation 4-Amino-substituted 1,2-dihydroxynaphthalene derivatives useful in inhibiting 5-lipoxygenase activity in mammals
IL92952A (en) 1990-01-03 1994-06-24 Teva Pharma R-enantiomers of n-propargyl-1-aminoindan compounds, their preparation and pharmaceutical compositions containing them
US5744500A (en) 1990-01-03 1998-04-28 Teva Pharmaceutical Industries, Ltd. Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
IL99759A (en) 1991-10-16 1997-06-10 Teva Pharma Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them
US5344836A (en) 1991-11-11 1994-09-06 Ono Pharmaceutical Co., Ltd. Fused benzeneoxyacetic acid derivatives
CH683996A5 (fr) 1992-03-05 1994-06-30 Symphar Sa Dérivés aminophosphonates substitués, leur procédé de préparation et compositions pharmaceutiques les contenant.
ATE219766T1 (de) 1993-04-07 2002-07-15 Otsuka Pharma Co Ltd N-acylierte 4-aminopiperidin derivate als aktive bestandteile von peripher gefässerweiternden wikstoffen
IL111240A (en) 1993-10-18 2001-10-31 Teva Pharma Salts of r(+) - enantiomers of n- propargyl-1-aminoindan and pharmaceutical compositions comprising them
US5877218A (en) 1994-01-10 1999-03-02 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
EP0738149B1 (en) * 1994-01-10 2006-11-29 Teva Pharmaceutical Industries, Ltd. 1-aminoindan derivatives and compositions thereof
CH690264A5 (fr) 1995-06-30 2000-06-30 Symphar Sa Dérivés aminophosphonates substitués, leur procédé de préparation et leur utilisation pour la préparation de compositions pharmaceutiques.
US5646188A (en) 1995-07-05 1997-07-08 Teva Pharmaceutical Industries, Ltd. Polyamine derivatives of 1-aminoindan
IL115357A (en) 1995-09-20 2000-01-31 Teva Pharma Stable compositions containing N-propargyl-1-aminoindan and polyhydric alcohols
US5887218A (en) 1996-06-10 1999-03-23 Ricoh Co., Ltd. Color image forming apparatus having toner and transfer sheet bearing members and image forming method thereof
ES2241064T3 (es) 1996-12-18 2005-10-16 Teva Pharmaceutical Industries, Ltd. Derivados de aminoindano.
US6251938B1 (en) 1996-12-18 2001-06-26 Teva Pharmaceutical Industries, Ltd., Phenylethylamine derivatives
WO1998055447A1 (en) 1997-06-05 1998-12-10 Venantius Limited 3-aminoindane derivatives, process for their preparation and pharmaceutical compositions containing them
US5887221A (en) 1997-10-20 1999-03-23 Xerox Corporation Signature sensing for optimum toner control with donor roll
US6227886B1 (en) 1999-04-16 2001-05-08 Avaya Technology Corp. Snag-resistant patchcord plug latch and cover

Also Published As

Publication number Publication date
DE60029131T2 (de) 2007-01-18
WO2001030339A1 (en) 2001-05-03
EP1242066A4 (en) 2004-09-01
EP1242066B1 (en) 2006-06-28
JP2003512426A (ja) 2003-04-02
EP1242066A1 (en) 2002-09-25
AU1440201A (en) 2001-05-08
CA2387394A1 (en) 2001-05-03
AU775885B2 (en) 2004-08-19
IL149308A (en) 2007-07-24
CA2387394C (en) 2009-08-18
IL149308A0 (en) 2002-11-10
DE60029131D1 (de) 2006-08-10
US6492426B1 (en) 2002-12-10

Similar Documents

Publication Publication Date Title
NZ514873A (en) 4,5,6,7-tetrahydroindazole derivatives as antitumor agents
UY25679A1 (es) Derivados de quinolin-2-ona inhibidores de la farnesil proteína transferasa útiles como agentes contra el cáncer
ATE283268T1 (de) 2-adamantylethylamine und deren verwendung bei der behandlung von abnormalitäten in der glutamat transmission
DE3671370D1 (de) Zubereitungen zur behandlung von mycoplasmosen und bakteriellen erkrankungen bei gefluegel.
NO944145D0 (no) Antiiskemisk medikament
FR2800735B1 (fr) Nouvelles aralkyle-1,2-diamines possedant une activite calcimimetique et leur mode de preparation
ATE184483T1 (de) Spirooxathiolan-quinuclidin-derivat zur behandlung des sjögren-syndroms
ATE218860T1 (de) Verwendung von 3,4-diphenylchromanen zur herstellung eines arzneimittels zur behandlung bzw. vorbeugung des prostatakarzinoms
ATE156359T1 (de) Phosphatdiester zur behandlung von proliferativen erkrankungen der epidermis
ATE331508T1 (de) Verwendung von 1-aminoindanderivaten zur behandlung der manie in verbindung mit manisch- depressiver erkrankung
UA21900A (uk) Похідhі глутатіоhу або їх фармацевтичhо прийhятhі солі, які проявляють протизапальhу, протиалергійhу та гепатотропhу активhість, і спосіб їх одержаhhя
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
ATE223379T1 (de) N-aryloxyethylaminderivate zur behandlung der depression
DK0951284T3 (da) Phenylethylminderivater
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
ATE236634T1 (de) Verwendung von 4-piperidinmethanolderivaten zur behandlung von neuralentwicklungsstörungen
ATE79863T1 (de) 1-alkyl-1-sulfonyl-2alkoxycarbonylsulfenylhydrazine mit antineoplasma-wirksamkeit.
ES2193047T3 (es) (3,4 dihydro-2h-benzo(1,4) oxazinilmetil)(3-(1h-indol-3-il)-alquil)-aminas.
DE69816832D1 (de) Verwendung von 8-nitro-2,3,4,5-tetrahydro-1h-3-benzazepinen zur herstellung von pharmazeutischen zusammenstellungen zur behandlung von schlafstörungen
DE69024385D1 (de) Verbindung zur Behandlung von Störungen des Neurotransmittersystems im Gehirn
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
DE60000405D1 (de) 1,4-disubstitutierte cyclohexanderivate zur behandlung von depression
SE9700803L (sv) Farmaceutisk komposition för behandling av s k restless legs
ATE64095T1 (de) Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis.
UY25593A1 (es) Procedimientos para preparar agentes terapeuticos utiles como inhibidores de la metaloproteasas de matriz (mmp)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties